XML 87 R27.htm IDEA: XBRL DOCUMENT v2.4.0.8
Segment and Geographic Information
 6 Months Ended
Oct. 24, 2014
Segment Reporting [Abstract]  
Segment and Geographic Information
Segment and Geographic Information
Segment information
The Company’s management evaluates performance and allocates resources based on profit and loss from operations before income taxes and interest expense, net, not including special charges, restructuring charges, net, certain litigation charges, net, and acquisition-related items. The accounting policies of the reportable segments are the same as those described in the summary of significant accounting policies in Note 1 to the consolidated financial statements included in the Company’s Annual Report on Form 10-K for the year ended April 25, 2014.
The Company operates under three reportable segments and three operating segments. The Company's Cardiac and Vascular Group consists of three businesses: Cardiac Rhythm & Heart Failure, Coronary & Structural Heart, and Aortic & Peripheral Vascular. The primary products sold by this operating segment include those for cardiac rhythm disorders and cardiovascular disease. The Company's Restorative Therapies Group consists of three businesses: Spine, Neuromodulation, and Surgical Technologies. The primary products sold by this operating segment include those for spinal conditions and musculoskeletal trauma, neurological disorders, urological and digestive disorders, and ear, nose, and throat conditions. The primary products sold by the Company's Diabetes Group include those for diabetes management.
Net sales of the Company’s reportable segments include end-customer revenues from the sale of products they each develop and manufacture or distribute. Net sales and earnings before income taxes by reportable segment are as follows:
 
Three months ended
 
Six months ended
(in millions)
October 24,
2014
 
October 25,
2013
 
October 24,
2014
 
October 25,
2013
Cardiac and Vascular Group
$
2,286

 
$
2,199

 
$
4,540

 
$
4,359

Restorative Therapies Group
1,650

 
1,602

 
3,253

 
3,156

Diabetes Group
430

 
393

 
846

 
762

Total Net Sales
$
4,366

 
$
4,194

 
$
8,639

 
$
8,277


 
Three months ended
 
Six months ended
(in millions)
October 24,
2014
 
October 25,
2013
 
October 24,
2014
 
October 25,
2013
Cardiac and Vascular Group
$
714

 
$
758

 
$
1,426

 
$
1,514

Restorative Therapies Group
426

 
443

 
836

 
864

Diabetes Group
117

 
107

 
237

 
182

Total Reportable Segments’ Earnings Before Income Taxes
1,257

 
1,308

 
2,499

 
2,560

Special charges
(100
)
 
—

 
(100
)
 
(40
)
Restructuring charges, net
—

 
—

 
(30
)
 
(18
)
Certain litigation charges, net
—

 
(24
)
 
—

 
(24
)
Acquisition-related items
(61
)
 
—

 
(102
)
 
96

Interest expense, net
(8
)
 
(33
)
 
(13
)
 
(73
)
Corporate
(66
)
 
(135
)
 
(149
)
 
(232
)
Earnings Before Income Taxes
$
1,022

 
$
1,116

 
$
2,105

 
$
2,269


Geographic information
Net sales to external customers by geography are as follows:
 
Three months ended
 
Six months ended
(in millions)
October 24,
2014
 
October 25,
2013
 
October 24,
2014
 
October 25,
2013
United States
$
2,456

 
$
2,338

 
$
4,789

 
$
4,544

Europe and Canada
1,035

 
1,035

 
2,116

 
2,081

Asia-Pacific
655

 
632

 
1,304

 
1,288

Other Foreign
220

 
189

 
430

 
364

Total Net Sales
$
4,366

 
$
4,194

 
$
8,639

 
$
8,277


Certain prior period net sales to external customers by geography have been corrected to conform to the current period classification. These revisions are considered immaterial.